Effect of cyclic AMP level reduction on human neutrophil responses to formylated peptides

Cellular Signalling

Volumn 8, Issue 4, 1996, Pages 269-277

  Spisani, Susanna ^a   Pareschi, Maria Cristina ^a   Buzzi, Marco ^a   Colamussi, Maria Luisa ^a   Biondi, Carla ^a   Traniello, Serena ^b   Zecchini, Giampiero Pagani ^b   Paradisi, Mario Paglialunga ^b   Torrini, Ines ^a   Ferretti, Maria Enrica ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adenosine deaminase; cAMP level reduction; Chemotaxis; Dipyridamole; Formylated peptides; Human neutrophils; Superoxide anion release

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENOSINE; ADENOSINE DEAMINASE; ADENYLATE CYCLASE; CLONIDINE; CYCLIC AMP; DIPYRIDAMOLE; ENZYME INHIBITOR; N (2 PHENYLCYCLOPENTYL)AZACYCLOTRIDECAN 2 IMINE; PEPTIDE; SUPEROXIDE;

ARTICLE; CHEMOTAXIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; SECOND MESSENGER;

EID: 0030176304     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/0898-6568(96)00049-6     Document Type: Article

References (38)

1. 1. Marasco W. A., Phan S. H., Krutzsch H., Showell H.J., Feltner D. E., Nairn R., Becker E. L. and Ward P.A. (1984) J. Biol. Chem. 259, 5430-5439.
2. 2. Verghese M. W., Fox K., McPhail L. C. and Snyderman R. (1985) J. Biol. Chem. 260, 6769-6775.
3. 3. Iannone M. A., Wolberg G. and Zimmerman T. P. (1989) J. Biol. Chem. 264, 20177-20180.
4. 4. Elliott K. R. F., Miller P. J., Stevenson H. C. and Leonard E. J. (1986) Biochem. Biophys. Res. Commun. 138, 1376-1382.
5. 5. Ferretti M. E., Spisani S., Pareschi M. C., Buzzi M., Cavallaro R., Traniello S., Reali E., Torrini I., Paglialunga Paradisi M., Pagani Zecchini G. and Biondi C. (1994) Cell. Signal. 6, 91-101.
6. 6. Tsu R. C., Allen R. A. and Wong Y. H. (1995) Mol. Pharmacol. 47, 835-841.
7. 7. Simchowitz L., Spilberg I. and Atkinson J. P. (1983) J. Cyclic Nucleotide Protein Phosphor. Res. 9, 35-47.
8. 8. Pagani Zecchini G., Paglialunga Paradisi M., Torrini I., Lucente G., Gavuzzo E., Mazza F., Pochetti G., Paci G., Sette M., Di Nola A., Veglia G., Traniello S. and Spisani S. (1993) Biopolymers 33, 437-451.
9. 9. Torrini I., Pagani Zecchini G., Paglialunga Paradisi M., Lucente G., Gavuzzo E., Mazza F., Pochetti G., Spisani S. and Giuliani A. L. (1991) Int. J. Peptide Protein Res. 38, 495-504.
10. 10. Spisani S., Giuliani A. L., Cavalletti T., Zaccarini M., Milani L., Gavioli R. and Traniello S. (1992) Inflammation 16, 147-158.
11. 11. Brown B. L., Ekins R. P. and Albano J. D. M. (1972) Adv. Cyclic Nucleotide Res. 2, 25-40.
12. 12. Zigmond S. H. and Hirsch J. G. (1973) J. Exp. Med. 137, 387-410.
13. 13. Savitha G. and Salimath B. P. (1993) Cell. Signal. 5, 107-117.
14. 14. Guellaen G., Mahu J. L., Mavier P., Berthelot P. and Hanoune J. (1977) Biochim. Biophys. Acta. 484, 465-475.
15. 15. Biondi C., Campi A. L., Pareschi M. C., Portolan A. and Ferretti M. E. (1990) Neurosci. Lett. 113, 322-327.
16. 16. Vesce F., Biondi C., Ferretti M. E., Pareschi M. C., Buzzi M. and Colamussi M. L. (1995) Gynecol. Obstet. Invest. 40, 73-79.
17. 17. Eckstein F., Cassel D., Levkovitz H., Lowe M. and Selinger Z. (1979) J. Biol. Chem. 254, 9829-9834.
18. 18. Cronstein B. N., Kramer S. B., Weissmann G. and Hirschhorn R. (1983) J. Exp. Med. 158, 1160-1177.
19. 19. Paterson A. R. P., Harley E. R., Kolassa N. and Cass C. E. (1981) Nucleotides and Cancer Treatment (Taffersil M. H. N. and Fox R. M., Eds.) pp. 3-17. Academic Press, New York.
20. 20. Daniels R. H., Bird I. N., Hill M. E. and Finnen M. J. (1993) Biochem. Pharmacol. 45, 1613-1620.
21. 21. Cronstein B. N., Rosenstein E. D., Kramer S. B., Weissmann G. and Hirschhorn R. (1985) J. Immunol. 135, 1366-1371.
22. 22. Cronstein B. N., Daguma L., Nichols D., Hutchison A. J. and Williams M. (1990) J. Clin. Invest. 85, 1150-1157.
23. 23. Marone G., Petracca R., Vigorita S. and Casolaro V. (1990) Biochem. Pharmacol. 40, 1963-1973.
24. 24. Riberio J. A. and Sebastiao A. M. (1986) Prog. Neurobiol. 26, 179-209.
25. 25. Pasini L. F., Capecchi P. L., Orrico A., Ceccatelli L. and Di Pierri T. (1985) J. Immunopharmacol. 7, 203-215.
26. 26. Van Calker D., Muller M. and Hamprecht B. (1979) J. Neurochem. 33, 999-1005.
27. 27. Wright C. D., Kuipers P. J., Kobylarz-Singer D., Devall L. J., Klinkefus B. A. and Weishaar R. E. (1990) Biochem. Pharmacol. 40, 699-707.
28. 28. Derian C. K., Santulli R. J., Rao P. E., Solomon H. F. and Barrett J. A. (1995) J. Immunol. 154, 308-317.
29. 29. Lad P. M., Goldberg B. J., Smiley P. A. and Olson C. V. (1985) Biochim. Biophys. Acta. 846, 286-295.
30. 30. Harvath L., Robbins J. D., Russel A. A. and Seamon K. B. (1991) J. Immunol. 146, 224-232.
31. 31. Anderson R., Glover A. and Rabson A. R. (1977) J. Immunol. 118, 1690-1696.
32. 32. Seligmann B. E., Fletcher M. P. and Gallin J. I. (1983) J. Immunol 130, 1902-1909.
33. 33. Elferink J. G. R. and de Koster B. M. (1993) Eur. J. Pharmacol. 246, 157-161.
34. 34. Schatz A. R., Kessler F. K. and Kaminski N. E. (1992) Life Sci. 51, PL 25-30.
35. 35. Koh W. S., Yang K. H. and Kammski N. E. (1995) Biochem. Biophys. Res. Commun. 206, 703-709.
36. 36. Tsuruta S., Ito S. and Mikawa H. (1992) Cell. Signal. 4, 543-551.
37. 37. Cronstein B. N., Duguma L., Nicholls D., Hutchison A. and Williams M. (1989) J. Clin. Invest. 85, 1150-1157.
38. 38. Salmon J. E. and Cronstein B. N. (1990) J. Immunol. 145, 2235-2240.